Capital raised by Maxymune Therapeutics
2 Form D filings · first filed Feb 2025 · Los Altos, CA
President & COO
Signatory on Maxymune Therapeutics's Form D filings · $2.7M raised across 2
Tatjana Naranda is on file as President & COO at Maxymune Therapeutics in Los Altos, CA. Maxymune Therapeutics has 2 Form D filings on record, $2.7M raised in total. Tatjana Naranda appears as a signatory on the company's filings.
No other people are on file at Maxymune Therapeutics. Form D filings only name the signatory and the company's executive officers.
Maxymune-01 is an advanced immunotherapy product designed to target specific pathways in the immune system, enhancing the body's natural ability to fight off diseases. This flagship offering is undergoing pivotal clinical trials to evaluate its safety and efficacy.
